Literature DB >> 33562883

Screening of Yeast Display Libraries of Enzymatically Treated Peptides to Discover Macrocyclic Peptide Ligands.

John Bowen1, John Schneible1, Kaitlyn Bacon1, Collin Labar2, Stefano Menegatti1,3, Balaji M Rao1,3.   

Abstract

We present the construction and screening of yeast display libraries of post-translationally modified peptides wherein site-selective enzymatic treatment of linear peptides is achieved using bacterial transglutaminase. To this end, we developed two alternative routes, namely (i) yeast display of linear peptides followed by treatment with recombinant transglutaminase in solution; or (ii) intracellular co-expression of linear peptides and transglutaminase to achieve peptide modification in the endoplasmic reticulum prior to yeast surface display. The efficiency of peptide modification was evaluated via orthogonal detection of epitope tags integrated in the yeast-displayed peptides by flow cytometry, and via comparative cleavage of putative cyclic vs. linear peptides by tobacco etch virus (TEV) protease. Subsequently, yeast display libraries of transglutaminase-treated peptides were screened to isolate binders to the N-terminal region of the Yes-Associated Protein (YAP) and its WW domains using magnetic selection and fluorescence activated cell sorting (FACS). The identified peptide cyclo[E-LYLAYPAH-K] featured a KD of 1.75 μM for YAP and 0.68 μM for the WW domains of YAP as well as high binding selectivity against albumin and lysozyme. These results demonstrate the usefulness of enzyme-mediated cyclization in screening combinatorial libraries to identify cyclic peptide binders.

Entities:  

Keywords:  WW domain; Yes Associated Protein (YAP) 65; cyclic peptide; transglutaminase; yeast display library

Year:  2021        PMID: 33562883      PMCID: PMC7915732          DOI: 10.3390/ijms22041634

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  76 in total

1.  Design of cyclic peptides that bind protein surfaces with antibody-like affinity.

Authors:  Steven W Millward; Stephen Fiacco; Ryan J Austin; Richard W Roberts
Journal:  ACS Chem Biol       Date:  2007-09-21       Impact factor: 5.100

2.  Potential of phage-displayed peptide library technology to identify functional targeting peptides.

Authors:  Lauren Rh Krumpe; Toshiyuki Mori
Journal:  Expert Opin Drug Discov       Date:  2007-04       Impact factor: 6.098

3.  Yeast surface display for screening combinatorial polypeptide libraries.

Authors:  E T Boder; K D Wittrup
Journal:  Nat Biotechnol       Date:  1997-06       Impact factor: 54.908

Review 4.  Small-molecule inhibitors of protein-protein interactions: progressing toward the reality.

Authors:  Michelle R Arkin; Yinyan Tang; James A Wells
Journal:  Chem Biol       Date:  2014-09-18

5.  The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin.

Authors:  W L Jorgensen; J Tirado-Rives
Journal:  J Am Chem Soc       Date:  1988-03-01       Impact factor: 15.419

6.  Reversible cyclic peptide libraries for the discovery of affinity ligands.

Authors:  Stefano Menegatti; Kevin Lawrence Ward; Amith Dattatray Naik; William Stanley Kish; Robert Kevin Blackburn; Ruben Guillermo Carbonell
Journal:  Anal Chem       Date:  2013-09-20       Impact factor: 6.986

7.  Tetrahydropyranyl, a nonaromatic acid-labile Cys protecting group for Fmoc peptide chemistry.

Authors:  Iván Ramos-Tomillero; Hortensia Rodríguez; Fernando Albericio
Journal:  Org Lett       Date:  2015-03-12       Impact factor: 6.005

8.  Engineering of TEV protease variants by yeast ER sequestration screening (YESS) of combinatorial libraries.

Authors:  Li Yi; Mark C Gebhard; Qing Li; Joseph M Taft; George Georgiou; Brent L Iverson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-15       Impact factor: 11.205

9.  Selective recognition of cyclic RGD peptides of NMR defined conformation by alpha IIb beta 3, alpha V beta 3, and alpha 5 beta 1 integrins.

Authors:  M Pfaff; K Tangemann; B Müller; M Gurrath; G Müller; H Kessler; R Timpl; J Engel
Journal:  J Biol Chem       Date:  1994-08-12       Impact factor: 5.157

Review 10.  The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities.

Authors:  Samuel Genheden; Ulf Ryde
Journal:  Expert Opin Drug Discov       Date:  2015-04-02       Impact factor: 6.098

View more
  4 in total

1.  Competitive blocking of LRP4-sclerostin binding interface strongly promotes bone anabolic functions.

Authors:  Svetlana Katchkovsky; Biplab Chatterjee; Chen-Viki Abramovitch-Dahan; Niv Papo; Noam Levaot
Journal:  Cell Mol Life Sci       Date:  2022-01-31       Impact factor: 9.261

Review 2.  New Horizons: Next-Generation Insulin Analogues: Structural Principles and Clinical Goals.

Authors:  Mark A Jarosinski; Yen-Shan Chen; Nicolás Varas; Balamurugan Dhayalan; Deepak Chatterjee; Michael A Weiss
Journal:  J Clin Endocrinol Metab       Date:  2022-03-24       Impact factor: 5.958

Review 3.  Recent Therapeutic Approaches to Modulate the Hippo Pathway in Oncology and Regenerative Medicine.

Authors:  Evan R Barry; Vladimir Simov; Iris Valtingojer; Olivier Venier
Journal:  Cells       Date:  2021-10-11       Impact factor: 6.600

Review 4.  Structural principles of insulin formulation and analog design: A century of innovation.

Authors:  Mark A Jarosinski; Balamurugan Dhayalan; Yen-Shan Chen; Deepak Chatterjee; Nicolás Varas; Michael A Weiss
Journal:  Mol Metab       Date:  2021-08-21       Impact factor: 7.422

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.